10/31/2024 3:42 PM | Coya Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/29/2024 7:00 AM | Coya Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/22/2024 8:08 AM | Coya Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/19/2024 8:10 AM | Coya Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/12/2024 7:04 AM | Coya Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/12/2024 7:13 AM | Coya Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
07/15/2024 5:10 AM | Coya Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
06/24/2024 4:31 PM | Coya Therapeutics (Filer)
| Form 424B3 | |
06/23/2024 11:15 PM | Coya Therapeutics (Filer)
| Form EFFECT | |
06/05/2024 7:00 PM | Coya Therapeutics (Issuer) Grossman Fred (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 7:00 PM | Berman Howard (Reporting) Coya Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 7:00 PM | Coya Therapeutics (Issuer) SNYDER DAVID S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/05/2024 7:00 AM | Coya Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 3:20 PM | Coya Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/08/2024 4:21 PM | Coya Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/28/2024 3:40 PM | Coya Therapeutics (Filer)
| Form ARS | |
03/28/2024 3:30 PM | Coya Therapeutics (Filer)
| Form DEF 14A | |
03/28/2024 3:35 PM | Coya Therapeutics (Filer)
| Form DEFA14A | |
03/19/2024 7:21 AM | Coya Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/19/2024 7:27 AM | Coya Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
03/05/2024 7:00 PM | Coya Therapeutics (Issuer) Lee Ann (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/14/2024 3:46 PM | Coya Therapeutics (Subject) GREENLIGHT CAPITAL INC (Filed by)
| Form SC 13G/A | |
02/07/2024 5:55 PM | Coya Therapeutics (Subject) HIRSCHMAN ORIN (Filed by)
| Form SC 13G/A | |
02/02/2024 7:00 PM | Berman Howard (Reporting) Coya Therapeutics (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 7:00 PM | Coya Therapeutics (Issuer) SNYDER DAVID S (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
02/02/2024 7:00 PM | Coya Therapeutics (Issuer) Grossman Fred (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 5:30 PM | Coya Therapeutics (Issuer) Villalobos Anabella (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 5:30 PM | Coya Therapeutics (Issuer) Lee Ann (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 5:30 PM | Coya Therapeutics (Issuer) GOLDSTEIN DOV A MD (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 5:30 PM | Coya Therapeutics (Issuer) Garren Hideki (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 5:30 PM | Coya Therapeutics (Issuer) Weinand Dieter (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
01/19/2024 7:15 AM | Coya Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
01/15/2024 11:15 PM | Coya Therapeutics (Filer)
| Form EFFECT | |
01/04/2024 3:46 PM | Coya Therapeutics (Filer)
| Form S-3 Registration statement under Securities Act of 1933 | |
01/04/2024 3:05 PM | Coya Therapeutics (Issuer) ROSS WILBUR L JR (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/29/2023 7:00 AM | Coya Therapeutics (Issuer) ROSS WILBUR L JR (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
12/20/2023 8:46 AM | Coya Therapeutics (Filer)
| Form D Notice of Exempt Offering of Securities | |
12/20/2023 7:35 AM | Coya Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/06/2023 6:30 AM | Coya Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2023 8:03 AM | Coya Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/08/2023 8:07 AM | Coya Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
625,000% Gain (Ad) Imagine swapping your daily coffee expense for a future free of financial worries.
It might seem far-fetched, but results like this are within reach with the right knowledge and timing in the altcoin market.
Plus, you’ll get $10 in real Bitcoin when you stay to the end of the call and take a short quiz. >> Dive into the Workshop Here |